G20
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: PATIENTS: - Existence of a written declaration of the informed consent after patient information - In the case of patients who are unable to give their consent: a written declaration by the informed consent of the legal representative after caregiver information - Sufficient knowledge of the German language to complete the questionnaires - Age = 18 years - Diagnosis of Parkinson's disease by a specialist in neurology accordingly the criteria of the Movement Disorder Society, certainty of diagnosis "probable ”, e.g. a maximum of two “red flags ”and more supporting criteria than “red flags ”. - Transition phase or late phase of the disease, defined as at least one of the following criteria: o Disturbing morning immobility or decrease in the drug effect at the end of the dose interval (anamnestic) o Occurrence of hypermobility (clinical) o Taking levodopa more than 4 times a day o Unexplained pain o Occurrence of hallucinations (at least once a month) o Cognitive deficits (anamnestic or external anamnestic) o More than one fall - If there is no transition or late phase, one of the following criteria: o Parkinson's tremor despite medication (clinical) o Disturbing daytime sleepiness or sleep disturbances o Impulse control disorder CAREGIVERS: - Relatives, supervisors or other main reference person in the study included patients - Existence of a written declaration of the informed consent after patient information - Sufficient knowledge of German language to complete the questionnaires - Age = 18 years - One caregiver per study patient
Exclusion criteria
Exclusion criteria: PATIENTS: The patient is incapable of giving consent AND does not have a family member with a proxy for health care or a legal representative CAREGIVERS: - Known cognitive impairment or other limitations that make participation in the study impossible (e.g. severely impaired hearing, and/or eyesight, and/or concentration or motor skills)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Parkinson's-specific quality of life Assessment using the validated measuring instrument Parkinson's Disease Quality of Life (PDQ) -39 (baseline, after 6 and after 12 months) | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Gait disorder Assessment with the Dresden Fall Frequency Questionnaire (DFQ) 2. Impulse control Assessment with the Questionnaire for impulsive-compulsive behaviors in Parkinson's (QUIP-RS) 3. Depression Assessment with Beck Depression Inventory (BDI II) 4. Psychoses Assessment with the Neuropsychiatric Inventory Questionnaire (NPI-Q) 5. Subjectively perceived quality of care /satisfaction with the care process Assessment with self-developed questionnaire on satisfaction with Parkinson's care 6. Degree of burden on caregivers Assessment with the Parkinson's Disease Caregiver Burden (PDCB) | — |
Countries
Germany
Contacts
Universitätsklinikum Carl Gustav Carus DresdenKlinik und Poliklinik für Neurologie